Presentation Information
[O8-1]A new genome editing therapy for MLII/III using the CRISPR/Cas3 and utilization of the RADDAR-J
○Yasuyuki Fukuhara1,2, Ryunosuke Sanada2, Tetsumin So1, Motomichi Kosuga1, Akihiro Umezawa2, Kenji Kurosawa1 (1.Center for Genetic Medicine, National Center for Child Health and Development, 2.Center for Regenerative Medicine, National Center for Child Health and Development)